Investigating the Sylvatic Transmission and Reservoir Potential of Zika, Dengue, and Chikungunya Viruses of Co-located Humans and Long-tailed Macaques of Thailand and Cambodia
| Registry | NCT04434846 |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 300 (Actual) |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) (Nih) |
| Conditions | Dengue Fever, Zika, Vector-Borne Diseases, Chikungunya |
| Dates | start 2021-02-08, primary completion 2021-05-07, completion 2021-05-07, first posted 2020-06-17, last updated 2024-04-26 |
| Locations | 1 site in Cambodia |
Related Papers Related Patents Related Grants Related Experts
All trials for Dengue Fever All trials for Zika
Background:
Zika, dengue, and chikungunya are spread by mosquitos. These diseases have a major impact on public health. This is especially true in in Southeast Asia. Non-human primates (such as macaques) could play an essential role in spreading these diseases. Researchers want to further understand the relationship between humans and these primates. They want to see how this affects how mosquito-borne viruses are spread in Southeast Asia.
Objective:
To describe the prevalence of Zika virus, dengue virus, and chikungunya virus in the blood of people who live close to long-tailed macaques in Thailand and Cambodia.
Eligibility:
Healthy people aged 18-55 who have lived or worked within approximately 10 kilometers of the Wat Amphae Phnom monkey habitat in Kampong Speu, Cambodia, for a minimum of 2 years
Design:
Participation will last 1 day.
Participants will be screened in person through an interview. Their medical history will be reviewed.
Participants will give information about themselves. This will include sex, age, and behaviors related to the spread of mosquito-borne disease. For example, they will be asked about the number of water containers at their home. They will be asked about recent travel. They will be asked about the extent of their contact with the macaques.
Participants will give a blood sample....
Arboviral epidemics continue to emerge suddenly and spread of disease is unpredictable. The 2015-16 Zika epidemic resulted in a high case number in Thailand, but not in neighboring Cambodia. It is known that nonhuman primates (NHPs) are important reservoirs of arboviruses, but the importance of their epidemiological role in the transmission of arboviruses is not clearly understood. While transmission dynamics are complex and require consideration of many variables, primate reservoirs are not routinely sampled, particularly in Southeast Asia, because of the level of operational complexity and skill required.
Here, we propose a serological survey for evidence of Zika virus (ZIKV), dengue virus (DENV), and chikungunya virus (CHIKV) exposure in long-tailed macaques and human adults who live or work in close proximity to these monkeys in Thailand and Cambodia. We hypothesize that ZIKV seroprevalence in both humans and macaques will be higher in Thailand than Cambodia. With the current rise of arboviral diseases around the world, we hope the results of this study contribute to better understanding of the epidemiology and burden of arboviral diseases in this region.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| 1 | Healthy Cambodian Adults aged 18-55 were screened for antibodies to ZIKV, DENV, and CHIKV at a single time point at Amphae Phnom, Chbar Mon, Cambodia. |
Sex: All, ages: 18 Years to 55 Years
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Provision of signed and dated ICF 2. Able to provide informed consent 3. Stated willingness to comply with study procedures 4. Male or female, aged 18-55 years 5. Live/work within approximately 10 km of the Wat Amphae Phnom monkey habitat for minimum of 2 years 6. In good general health as evidenced by screening medical history 7. Willing to allow biological samples to be stored for future research EXCLUSION CRITERIA: 1\. Any underlying, chronic, or current medical condition that, in the opinion of the investigator, would interfere with participation in the study (e.g., inability or great difficulty in drawing blood)
| Milestone | Cambodian Adults in Observational Cross-Sectional Study of Arboviral Exposure |
|---|---|
| Started | 300 |
| Completed | 300 |
| Not completed | 0 |
Time frame: This was a cross sectional bioprocurement protocol with a one-time blood draw. Adverse events were monitored on that day, participants exited the study the same day but were always able to call study team - up to three months after study exit - should an adverse event have occurred from a low-risk procedure such as phlebotomy. The enrollment and monitoring period was during the month of February 2020.
| Arm | Deaths | Serious adverse events | Other adverse events |
|---|---|---|---|
| 300 Adults Ages 18-55 With ZIKV, DENV, and/or CHIKV Seroprevalence. | 0/300 (0.0%) | 0/300 (0.0%) | 0/300 (0.0%) |
| Facility | City | Country | Status |
|---|---|---|---|
| National Malaria Center | Phnom Penh | Cambodia |